Haleon plc (HLN) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
↓
13.50
↓-35% vs avg
5yr avg: 20.72
30Y Low19.1·High22.1
P/FCF
↑
15.30
↓-30% vs avg
5yr avg: 21.84
30Y Low21.3·High23.1
P/B Ratio
↑
1.85
↓-26% vs avg
5yr avg: 2.50
30Y Low2.2·High2.8
ROE
↑
10.0%
↓+41% vs avg
5yr avg: 7.1%
30Y Low2%·High10%
Debt/EBITDA
↑
3.10
↓-8% vs avg
5yr avg: 3.37
30Y Low0.3·High4.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
HLN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Haleon plc trades at 18.8x earnings, 40% below its 5-year average of 31.4x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 15%. On a free-cash-flow basis, the stock trades at 15.3x P/FCF, 30% below the 5-year average of 21.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $39.9B | $45.6B | $43.8B | $38.1B | $37.0B | — | — | — |
| Enterprise Value | $49.5B | $52.8B | $51.7B | $46.5B | $46.7B | — | — | — |
| P/E Ratio → | 18.81 | 28.08 | 29.81 | 34.29 | 33.33 | — | — | — |
| P/S Ratio | 2.80 | 4.22 | 3.90 | 3.37 | 3.40 | — | — | — |
| P/B Ratio | 1.85 | 2.77 | 2.70 | 2.28 | 2.25 | — | — | — |
| P/FCF | 15.30 | 23.11 | 21.34 | 21.61 | 21.30 | — | — | — |
| P/OCF | 13.19 | 19.93 | 19.02 | 18.15 | 17.91 | — | — | — |
P/E links to full P/E history page with 30-year chart
HLN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Haleon plc's enterprise value stands at 13.5x EBITDA, 35% below its 5-year average of 20.7x. The Healthcare sector median is 14.2x, placing the stock at a 5% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.90 | 4.60 | 4.12 | 4.30 | — | — | — |
| EV / EBITDA | 13.50 | 19.05 | 21.51 | 20.19 | 22.12 | — | — | — |
| EV / EBIT | 15.46 | 21.82 | 22.29 | 22.79 | 24.64 | — | — | — |
| EV / FCF | — | 26.80 | 25.19 | 26.38 | 26.92 | — | — | — |
HLN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Haleon plc earns an operating margin of 22.4%. Operating margins have expanded from 17.7% to 22.4% over the past 3 years, signaling improving operational efficiency. ROE of 10.0% is modest. ROIC of 7.6% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.8% | 64.8% | 61.9% | 61.6% | 60.6% | 62.3% | 59.7% | 56.6% |
| Operating Margin | 22.4% | 22.4% | 19.6% | 17.7% | 16.8% | 17.2% | 16.2% | 10.6% |
| Net Profit Margin | 15.1% | 15.1% | 12.8% | 9.3% | 9.8% | 14.6% | 11.6% | 7.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | 10.0% | 10.0% | 8.8% | 6.3% | 4.9% | 5.3% | 4.3% | 2.4% |
| ROA | 4.9% | 4.9% | 4.2% | 3.0% | 3.1% | 4.1% | 3.3% | 1.8% |
| ROIC | 7.6% | 7.6% | 6.7% | 5.8% | 5.1% | 4.6% | 4.4% | 2.4% |
| ROCE | 8.6% | 8.6% | 7.6% | 6.7% | 6.0% | 5.4% | 5.2% | 2.9% |
HLN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Haleon plc carries a Debt/EBITDA ratio of 3.1x, which is moderately leveraged (roughly in line with the sector average of 3.2x). Net debt stands at $7.3B ($8.6B total debt minus $1.3B cash). Interest coverage of 7.3x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.52 | 0.52 | 0.62 | 0.57 | 0.63 | 0.04 | 0.02 | 0.02 |
| Debt / EBITDA | 3.10 | 3.10 | 4.21 | 4.10 | 4.94 | 0.52 | 0.26 | 0.55 |
| Net Debt / Equity | — | 0.44 | 0.49 | 0.50 | 0.59 | 0.02 | 0.01 | 0.01 |
| Net Debt / EBITDA | 2.62 | 2.62 | 3.29 | 3.65 | 4.62 | 0.30 | 0.08 | 0.26 |
| Debt / FCF | — | 3.69 | 3.86 | 4.77 | 5.62 | 0.55 | 0.14 | 0.56 |
| Interest Coverage | 7.28 | 7.28 | 5.60 | 4.82 | 5.25 | 102.38 | 62.31 | 31.96 |
HLN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.92x is below 1.0, meaning current liabilities exceed current assets — though the company's $1.3B cash position helps mitigate short-term liquidity concerns. The current ratio has declined from 1.04x to 0.92x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.92 | 0.92 | 0.98 | 1.04 | 0.93 | 1.24 | 1.25 | 1.36 |
| Quick Ratio | 0.71 | 0.71 | 0.78 | 0.73 | 0.62 | 1.01 | 1.01 | 1.08 |
| Cash Ratio | 0.27 | 0.27 | 0.39 | 0.23 | 0.16 | 0.10 | 0.08 | 0.08 |
| Asset Turnover | — | 0.33 | 0.33 | 0.33 | 0.31 | 0.28 | 0.29 | 0.24 |
| Inventory Turnover | 3.71 | 3.71 | 3.60 | 3.08 | 3.18 | 3.78 | 4.20 | 3.04 |
| Days Sales Outstanding | — | 71.70 | 61.87 | 43.66 | 49.99 | 146.27 | 49.74 | 171.91 |
HLN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Haleon plc returns 4.1% to shareholders annually — split between a 2.0% dividend yield and 2.1% buyback yield. The payout ratio of 36.7% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 5.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.0% | 1.3% | 1.3% | 1.0% | 7.3% | — | — | — |
| Payout Ratio | 36.7% | 36.7% | 39.5% | 37.0% | 253.0% | 82.6% | 207.1% | 175.9% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.3% | 3.6% | 3.4% | 2.9% | 3.0% | — | — | — |
| FCF Yield | 6.5% | 4.3% | 4.7% | 4.6% | 4.7% | — | — | — |
| Buyback Yield | 2.1% | 1.4% | 0.3% | 0.1% | 0.0% | — | — | — |
| Total Shareholder Yield | 4.1% | 2.7% | 1.6% | 1.1% | 7.3% | — | — | — |
| Shares Outstanding | — | $4.5B | $4.6B | $4.6B | $4.6B | $4.6B | $4.6B | $4.6B |
Peer Comparison
Compare HLN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 HLNYou | $40B | 18.8 | 13.5 | 15.3 | 64.8% | 22.4% | 10.0% | 7.6% | 3.1 |
 KVUE | $35B | 23.8 | 13.0 | 20.2 | 58.1% | 17.9% | 14.4% | 11.4% | 2.6 |
 CHD | $23B | 31.7 | 18.5 | 20.7 | 44.7% | 17.4% | 17.6% | 13.9% | 1.7 |
 PG | $351B | 23.1 | 16.2 | 25.0 | 51.2% | 24.3% | 31.1% | 20.1% | 1.5 |
 CL | $72B | 34.0 | 15.8 | 19.8 | 60.1% | 21.3% | 469.1% | 43.4% | 1.6 |
 PBH | $2B | 12.0 | 9.4 | 8.8 | 52.8% | 28.4% | 10.2% | 8.2% | 3.1 |
 JNJ | $550B | 39.4 | 19.1 | 27.7 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 |
 NVS | $281B | 20.5 | 13.7 | 15.9 | 75.0% | 31.2% | 31.0% | 18.8% | 1.7 |
 GSK | $102B | 6.9 | 8.6 | 13.2 | 72.4% | 25.5% | 39.4% | 22.1% | 1.7 |
 MCK | $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 |
 CAH | $52B | 34.4 | 18.8 | 28.2 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into HLN consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
HLN — Frequently Asked Questions
Quick answers to the most common questions about buying HLN stock.
What is Haleon plc's P/E ratio?
Haleon plc's current P/E ratio is 18.8x. The historical average is 31.4x.
What is Haleon plc's EV/EBITDA?
Haleon plc's current EV/EBITDA is 13.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.7x.
What is Haleon plc's ROE?
Haleon plc's return on equity (ROE) is 10.0%. The historical average is 6.0%.
Is HLN stock overvalued?
Based on historical data, Haleon plc is trading at a P/E of 18.8x. Compare with industry peers and growth rates for a complete picture.
What is Haleon plc's dividend yield?
Haleon plc's current dividend yield is 1.96% with a payout ratio of 36.7%.
What are Haleon plc's profit margins?
Haleon plc has 64.8% gross margin and 22.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Haleon plc have?
Haleon plc's Debt/EBITDA ratio is 3.1x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.